RecruitingNCT07291908

Inflammation Severity and miRNA-126 in Trauma

Correlation of Inflammation Severity With Pulmonary Gas Exchange and MiRNA 126 in Trauma Patients


Sponsor

Melike Cengiz

Enrollment

130 participants

Start Date

Jun 17, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Trauma triggers a complex immune response intended to eliminate danger signals and restore physiological balance. Early post-traumatic inflammation is primarily initiated by damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). In patients with severe trauma, dysregulated inflammation increases susceptibility to infection, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), and mortality. The lungs are particularly vulnerable, and excessive inflammatory activation may lead to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), conditions characterized by increased vascular permeability, alveolar epithelial injury, surfactant dysfunction, and impaired gas exchange. Pro-inflammatory cytokines, activated neutrophils, reactive oxygen species, and proteases contribute to endothelial and epithelial barrier disruption. Recent evidence also suggests that several microRNAs, including miR-126, may play a regulatory role in pulmonary barrier integrity through modulation of tight-junction proteins and PI3K/AKT-related pathways. Although many components of the trauma-related inflammatory response have been described, the relationship between systemic inflammatory severity and impairment of pulmonary gas exchange remains insufficiently defined in clinical settings. This study aims to investigate the correlation between inflammatory severity markers (C-reactive protein, procalcitonin, IL-6, reactive oxygen derivatives, neutrophil-to-lymphocyte ratio, lactate), imaging findings (flow-mediated dilation by ultrasound), clinical parameters (blood pressure, heart rate, urine output, vasoactive medication requirements), pulmonary gas-exchange measurements (arterial blood gases, PaO₂/FiO₂ ratio), and circulating miRNA-126 levels in trauma patients. The findings may help identify biomarkers that better reflect inflammatory burden and the risk of lung dysfunction following trauma.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Adults aged 18 years or older.
  • Patients monitored and treated for trauma in the anesthesia intensive care units of Akdeniz University Faculty of Medicine.

Exclusion Criteria8

  • Patients younger than 18 years.
  • Patients with concomitant thoracic trauma.
  • Presence of active infection prior to trauma.
  • Patients not admitted to the ICU within the first 24 hours after trauma.
  • Patients who remain in the ICU for less than 72 hours following trauma.
  • Current use of steroids, chemotherapy, or antibiotic therapy prior to ICU admission.
  • Patients with immunodeficiency.
  • Patients who are in shock prior to or during ICU admission.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Akdeniz University Hospital

Antalya, Ağrı, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07291908


Related Trials